Download PDF
Thromb Haemost 1967; 17(03/04): 482-490
DOI: 10.1055/s-0038-1654172
Originalarbeiten - Original Articles - Travaux Originaux
Schattauer GmbH

Influence of Plasma Lipoproteins on the Fibrinolytic Activity

Z Skrzydlewski
1   Department of Physiological Chemistry and Second Department of Obstetrics and Gynaecology, Medical School, Białystok (Poland)
,
S Niewiarowski
1   Department of Physiological Chemistry and Second Department of Obstetrics and Gynaecology, Medical School, Białystok (Poland)
› Author Affiliations
Further Information

Publication History

Publication Date:
26 June 2018 (online)

Also available at
    Permissions and Reprints

Summary

Native lipoprotein fractions : alpha, beta and chylomicrons have been isolated from human serum according to the method of Burstein. Alpha lipoproteins and chylomicrons do not inhibit plasmin. The antiplasmin activity of beta lipoprotein amounts to about 10% of the total plasma antiplasmin activity. It is inactivated during heating at 56° C for 10 min, while storing at 4° C for a few days and by chloroform treatment. About 50% of serum beta lipoprotein is precipitated in euglobulin fraction. Variations of serum beta lipoprotein level have a significant effect on euglobulin fibrinolysis. Beta lipoprotein level, beta lipoprotein antiplasmin activity and euglobulin fibrinolysis have been determined in 2 groups of lipemic patients : a) puerperal women, b) patients with advanced atherosclerosis. There is a close correlation of beta lipoprotein level and euglobulin fibrinolysis time in puerperal patients. The inhibition of euglobulin fibrinolysis in patients with atherosclerosis depends on several factors, and only partly of the beta lipoprotein level. Beta lipoprotein level and beta lipoprotein antiplasmin activity were well correlated in both groups of patients.

 

  • References

  • 1 Bang N. U, Cliffion E. E. The effect of alimentary hyperlipemia on thrombolysis in vivo Thrombos. Diathes. haemorrh. (Stuttg.) 4: 149 1960;
    PubMedGoogle Scholar
  • 2 Billimoria J. D, James J, Drysdale D. G. O, Maclagan N. F. Determination of fibrinolytic activity of whole blood. Lancet II: 471 1959;
    PubMedGoogle Scholar
  • 3 Blix S. Studies on the fibrinolytic system in the euglobulin fraction of human plasma. Scand. J. clin. Lab. Invest. 13 58 1961
    PubMedGoogle Scholar
  • 4 Buckell M, Elliot F. A. Effect of butter lipaemia on the rate of clot lysis in normal males. Lancet 1: 662 1959;
    PubMedGoogle Scholar
  • 5 Burstein M, Fine J. M. Isolement d’une fraction des alpha1-ipoproteines sèriques après précipitation par le sulfate de dextrane en présence des cations bivalents et de saccharose. Rev. franç. Étud. clin. biol 9: 195 1964;
    PubMedGoogle Scholar
  • 6 Burstein M, Samaille J. Nouvelle methode de séparation et de dosage des lipoprotéines de faible densité. Ann. biol. Clin 17: 23 1959;
    PubMedGoogle Scholar
  • 7 Burstein M, Samaille J. Dosage des beta-lipoproteines sèriques après précipitation sélective par l’héparine. Presse méd 66: 974 1958;
    PubMedGoogle Scholar
  • 8 Christensen L. R. Activation of plasminogen by chlorofrom. J. gen. Physiol 30: 149 1947;
    PubMedGoogle Scholar
  • 9 Delezenne C, Pozerski E. Action du sérum sanguin sur la gélatine en présence du chloroforme. C. R. Soc. Biol. (Paris) 55: 327 1903;
    PubMedGoogle Scholar
  • 10 Denys J, Marbaix H. Sur les peptonisations provoquées par le chlorofrome et quelques autres substances. Cellule 5: 193 1889;
    PubMedGoogle Scholar
  • 11 Farquhar J. W, Merigan T. G, Sokolow M. Plasma fibrinolysis in man: the effect of chylomicrons derived from different deitary fats. J. exp. Med 113: 587 1961;
    CrossrefPubMedGoogle Scholar
  • 12 Gillman T, Naidoo S. S, Hathorn M. Fat, fibrinolysis and atherosclerosis in Africans. Lancet II: 696 1957;
    PubMedGoogle Scholar
  • 13 Greig H. B. W. Inhibition of fibrinolysis by alimentary lipaemia. Lancet II: 16 1956;
    PubMedGoogle Scholar
  • 14 Greig H. B. W, Runde J. A. Studies on the inhibition et fibrinolysis by lipids. Lancet II: 461 1957;
    PubMedGoogle Scholar
  • 15 Hougie G, Ayers F. Lipaemia and fibrinolytic potentiality. Lancet I: 186 1960;
    PubMedGoogle Scholar
  • 16 Howell M. Effects of plasma lipids on fibrinolysis. Brit. med. Bull 20: 200 1964;
    CrossrefPubMedGoogle Scholar
  • 17 Jacobsen C. D. The caseinolytic method for determination of plasminogen-plasmin in human plasma and serum. Scand. J. clin. Lab. Invest 16: 372 1964;
    CrossrefPubMedGoogle Scholar
  • 18 Kekwick R. A, MacKay N. E, Nance M. H, Record B. R. The purification of human fibrinogen. Biochem. J 60: 671 1955;
    PubMedGoogle Scholar
  • 19 Konttinen Y. On the effect of alimentary lipaemia and a natural heparinoid on the fibrinolytic system of man. Scand. J. clin. Lab. Invest 14: 87 1961;
    PubMedGoogle Scholar
  • 20 Kowalski E, Kopec M, Niewiarowski S. An evaluation of the euglobulin method for the determination of fibrinolysis. J. clin. Path 12: 215 1959;
    CrossrefPubMedGoogle Scholar
  • 21 Lackner H. Sougin-Mibashan Fibrinolysis in relation to lipaemia and intravenous heparin in the White and Bantu. S. Afr. med. J 35: 364 1961;
    PubMedGoogle Scholar
  • 22 Lewis J. H, Ferguson J. H. Studies on a proteolytic enzyme system of the blood. IV. Activation of Profibrinolysin by serum fibrinolysokinase. Proc. Soc. exp. Biol. (N. Y.) 78: 184 1951;
    CrossrefPubMedGoogle Scholar
  • 23 Moga A, Baciu I, Pitea P, Cucuianu M, Suciu A. Sistemul fibrinolytic synguin in atheromatoza umana. Stud. Cercet. Med. (Cluj) 11: 97 1960;
    PubMedGoogle Scholar
  • 24 Moser K. M, Hajjar G. C. Age and disease related alterations in fibrinogeii-euglobulin (fibrinolytic) behaviour. Amer. J. med. Sci 251: 536 1966;
    CrossrefPubMedGoogle Scholar
  • 25 Niewiarowska M, Węgrzynowicz Z. Influence of dicoumarol derivatives on plasma fibrinolytic system. Thrombos. Diathes. haemorrh. (Stuttg.) 3: 279 1959;
    PubMedGoogle Scholar
  • 26 Nitzberg S. I, Peyman M. A, Goldstein R, Proger S. Studies of blood coagulation and fibrinolysis in patients with idiopathic hyperlipemia and primary hypercholesteremia before and after a fatty meal. Circulation 19: 676 1959;
    CrossrefPubMedGoogle Scholar
  • 27 Ogston D, Fullerton H. W. Effect of alimentary lipaemia on plasma fibrinolytic activity. Brit. med. J 2: 1288 1962;
    CrossrefPubMedGoogle Scholar
  • 28 Pappenhagen A. R, Koppel J. L, Olwin J. H. Observations on the in vitro effects of chylomicra low-density lipoproteins and phospholipids on human plasma euglobulin lysis. Thrombos. Diathes. haemorrh. (Stuttg.) 9: 164 1963;
    PubMedGoogle Scholar
  • 29 Riding I. M, Ellis D. Antiplasmin activity of beta-lipoprotein. J. Atheroscler. Res 4: 189 1964;
    CrossrefPubMedGoogle Scholar
  • 30 Sarkar N. Reduced fibrinolytic activity of atherosclerotic sera caused by an increase in low-density lipoproteins in blood. Nature 189: 929 1961;
    CrossrefPubMedGoogle Scholar
  • 31 Shamash Y, Rimon A. The plasmin inhibitors of plasma. I. A method for their estimation. Thrombos. Diathes. haemorrh 12: 119 1964;
    PubMedGoogle Scholar
  • 32 Shaper A. G, Jones K. W, Kyobe J, Jones M. Fibrinolysis in relation to body fatness, serum lipids and coronary heart disease in African and Asian men in Uganda. J. Atheroscler. Res 6: 313 1966;
    CrossrefPubMedGoogle Scholar
  • 33 Skrzydlewski Z, Niewiarowski S, Skrzydlewska J. Inhibition of proteolytic enzymes by beta-lipoprotein. J. Atheroscler. Res 6: 273 1966;
    CrossrefPubMedGoogle Scholar
  • 34 Sweet B, Rifkind B. M, McNicol G. P. The relationship between blood lipids and the fibrinolytic enzyme system. J. Atheroscler. Res 6: 359 1966;
    CrossrefPubMedGoogle Scholar
  • 35 Tagnon H. J, Davidson C. S, Taylor F. H. L. Studies of blood coagulation. A proteolytic enzyme prepared from calcium and platelet free normal human blood plasma. J. clin. Invest 22: 525 1942;
    PubMedGoogle Scholar
  • 36 Walker A. R. P. Fibrinolytic activity of whole blood from south African Bantu and White subjects. Amer. J. clin. Nutr 9: 461 1961;
    PubMedGoogle Scholar